Coherus Oncology (CHRS) Revenue (QoQ) (2013 - 2026)
Coherus Oncology (CHRS) Revenue (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.44% |
| Dec 31, 2025 | 10.17% |
| Sep 30, 2025 | 12.84% |
| Jun 30, 2025 | 34.94% |
| Mar 31, 2025 | -1.73% |
| Dec 31, 2024 | 27.78% |
| Sep 30, 2024 | -41.22% |
| Jun 30, 2024 | 346.10% |
| Mar 31, 2024 | -97.48% |
| Dec 31, 2023 | 22.74% |
| Sep 30, 2023 | 27.00% |
| Jun 30, 2023 | 81.02% |
| Mar 31, 2023 | -28.48% |
| Dec 31, 2022 | -0.16% |
| Sep 30, 2022 | -24.48% |
| Jun 30, 2022 | 0.06% |
| Mar 31, 2022 | -18.04% |
| Dec 31, 2021 | -11.09% |
| Sep 30, 2021 | -5.87% |
| Jun 30, 2021 | 5.55% |